Testing for Germline/Somatic BRCA Mutations in Metastatic CRPC - Targeted Oncology
8/8/2022 12:00:00 AM2 years 9 months ago
by Alan Bryce, MD, Eleni Efstathiou, MD, Daniel Landau, MD
by Alan Bryce, MD, Eleni Efstathiou, MD, Daniel Landau, MD
A brief discussion on the importance of germline/somatic BRCA1 and BRCA2 mutations in metastatic CRPC, accompanied by practical advice on genetic testing.
Transcript: Alan Bryce, MD: Lets go back to Eleni here. Number 1, do you repeat genetic testing in patients at progression? What are the guidelines around testing for germline/somatic mutations? We'… [+5240 chars]
full article...